BRIEF-M Pharmaceutical agrees to acquire assets from Chelatexx

Wed Apr 6, 2016 6:18am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 6 (Reuters) - M Pharmaceutical Inc

* Signs definitive agreement to acquire reformulated orlistat for weight loss from Chelatexx LLC

* Says addition of C-103 provides a novel weight loss pharmaceutical product to M Pharma pipeline

* Entered into a definitive agreement to acquire assets from Chelatexx LLC related to a reformulated version of orlistat

* Company also announced it was undertaking a non-brokered private placement of up to $700,000 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)